Spots Global Cancer Trial Database for Use of 852A in Metastatic Cutaneous Melanoma.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Use of 852A in Metastatic Cutaneous Melanoma.
Official Title: Pilot Phase II, Open Label, Multicenter, Efficacy and Safety Study of 852A Administered Intravenously to Subjects With Unresectable Metastatic Cutaneous Melanoma.
Study ID: NCT00189332
Interventions
Study Description
Brief Summary: Pilot study to test the efficacy of 852A administered intravenously up to 3 times per week for 12 weeks in subjects with inoperable metastatic cutaneous melanoma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
HĂ´pital Hotel Dieu, 1, Pace de l' HĂ´pital,, Lyon, , France
HĂ´pital Ste Marguerite,Service de Dermatologie, Marseilles, , France
Hautklinik, Medizinische Einrichtungen der Heinrich-Heine - Universität Dßsseldorf, Dßsseldorf, , Germany
Klinik und Poliklinik fßr Dermatologie und Venerologie Universitätsklinikum Essen, Essen, , Germany
Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, , Germany
(DKFZ) an der Universitäts-Hautklinik Mannheim, Mannheim, , Germany
Universitätsklinik und Poliklinik fßr Hautkrankheiten, Wßrzburg, , Germany
Universitatsspital Zurich, Zurich, , Switzerland
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
